title: Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia.
authors.affiliation: Department of Psychiatry, Yale University, 34 Park St., New Haven, CT 06519, USA.
authors.forename: Sharmin
authors.initials: S
authors.lastname: Ghaznavi
authors.forename: Marina
authors.initials: M
authors.lastname: Nakic
authors.forename: Paul
authors.initials: P
authors.lastname: Rao
authors.forename: Jian
authors.initials: J
authors.lastname: Hu
authors.forename: Judson A
authors.initials: JA
authors.lastname: Brewer
authors.forename: Jonas
authors.initials: J
authors.lastname: Hannestad
authors.forename: Zubin
authors.initials: Z
authors.lastname: Bhagwagar
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D012008:Recurrence; D018967:Risperidone / Q000627:therapeutic use*; D012563:Schizophrenia, Paranoid / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D012720:Severity of Illness Index
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine; D018967:Risperidone